KANYRPHARMA.COM

Home

Kanyr, the world’s leading PTP inhibitor company. Capitalize on existing expertise and local resources. Minimal competition in the PTP area. Many PTP targets available and left untapped. Montreal, QC, Canada. Contact: Daniel Bouthillier 514-402-1764. Email us: daniel.bouthillier@kaneq.ca. PTPs have long been thought to be undruggable . Recent successes. Show that this is no longer the case:. PTPβ inhibitor in P1 development for diabetic macular edema. PTP Inhibitor Immunotherapy ImmunyrTM Technology.

http://www.kanyrpharma.com/

OVERVIEW OF kanyrpharma.com

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

4

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR KANYRPHARMA.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

December

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Saturday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 4.4 out of 5 with 15 reviews

5 star

9

4 star

5

3 star

0

2 star

0

1 star

1

Hey there! Start your review of kanyrpharma.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

0.2 seconds

FAVICON PREVIEW

16x16
32x32
64x64
128x128
160x160
192x192
256x256

CONTACTS AT KANYRPHARMA.COM

Domains By Proxy, LLC

Registration Private

Domain●●●●●●xy.com

14747 N Norths●●●●●●●●●●●●●●e 111, PMB 309

Sco●●●ale , Arizona, 85260

UNITED STATES

1480●●●●2599

1480●●●●2598

KA●●●●●●●●●●●●●@domainsbyproxy.com

View this contact

Domains By Proxy, LLC

Registration Private

Domain●●●●●●xy.com

14747 N Norths●●●●●●●●●●●●●●e 111, PMB 309

Sco●●●ale , Arizona, 85260

UNITED STATES

1480●●●●2599

1480●●●●2598

KA●●●●●●●●●●●●●@domainsbyproxy.com

View this contact

Domains By Proxy, LLC

Registration Private

Domain●●●●●●xy.com

14747 N Norths●●●●●●●●●●●●●●e 111, PMB 309

Sco●●●ale , Arizona, 85260

UNITED STATES

1480●●●●2599

1480●●●●2598

KA●●●●●●●●●●●●●@domainsbyproxy.com

View this contact

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED: 2014 April 03
UPDATED: 2014 April 03
EXPIRATION: EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

DOMAIN AGE

11

YEARS
6

MONTHS
30

DAYS

NAME SERVERS

1: ns29.domaincontrol.com
2: ns30.domaincontrol.com

REGISTRAR

GODADDY.COM, LLC

WHOIS : whois.godaddy.com

REFERRED : http://registrar.godaddy.com

CONTENT

PAGES IN
THIS WEBSITE

4

SSL

EXTERNAL LINKS

2

SITE IP

208.109.181.138

LOAD TIME

0.187 sec

SCORE

6.2

PAGE TITLE

Home | kanyrpharma.com Reviews

<META> DESCRIPTION

Kanyr, the world’s leading PTP inhibitor company. Capitalize on existing expertise and local resources. Minimal competition in the PTP area. Many PTP targets available and left untapped. Montreal, QC, Canada. Contact: Daniel Bouthillier 514-402-1764. Email us: daniel.bouthillier@kaneq.ca. PTPs have long been thought to be undruggable . Recent successes. Show that this is no longer the case:. PTPβ inhibitor in P1 development for diabetic macular edema. PTP Inhibitor Immunotherapy ImmunyrTM Technology.

<META> KEYWORDS

1 for information

2 ptps opportunity

3 aerpio therapeutics akb 9778

4 kaneq bioscience kq 791

5 prl ptp inhibitor and

6 summary

7 about us

8 programs

9 management team

CONTENT

Page content here

KEYWORDS ON PAGE

SERVER

Apache

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

Home | kanyrpharma.com Reviews

https://kanyrpharma.com

Kanyr, the world’s leading PTP inhibitor company. Capitalize on existing expertise and local resources. Minimal competition in the PTP area. Many PTP targets available and left untapped. Montreal, QC, Canada. Contact: Daniel Bouthillier 514-402-1764. Email us: daniel.bouthillier@kaneq.ca. PTPs have long been thought to be undruggable . Recent successes. Show that this is no longer the case:. PTPβ inhibitor in P1 development for diabetic macular edema. PTP Inhibitor Immunotherapy ImmunyrTM Technology.

INTERNAL PAGES

kanyrpharma.com

1

About us

http://www.kanyrpharma.com/about-us.html

Abundant evidence supporting the cancer promoting roles of PRL-PTP and other phosphatases in cancer immunotherapy. These are one of the top untapped targets for anti-cancer therapy. Identified as a difficult target. Shallow and wide catalytic pocket. Currently no known activity on PRL inhibitor development or appllication in immunotherapy with anti-PTP inhibitor. Proprietary data on targeting PRL/CNNM complex and other PTPs provide head start on competition. Kanyr was incorporated in May 2013.

2

Programs

http://www.kanyrpharma.com/programs.html

The phosphatases of regenerating liver (PRLs) PTPs are the most oncogenic enzymes of the PTP gene family. These are small (Mr 20,000) single PTP domain enzymes comprising three highly homologous members (PRL-1,-2,-3). All PRLs are oncogenes and promote cell proliferation, tumour growth, invasion, and metastasis in over 90% of all cancers. However, the underlying molecular mechanism behind their oncogenicity remains unknown. Kanyr identified a key PTP that negatively modulates dendritic cell activation.

3

Management Team

http://www.kanyrpharma.com/management-team-1.html

15 years of PTP research. Michel L. Tremblay Ph.D., F.R.S.C. Full Professor, Jeanne and Jean-Louis Levesque Chair in Cancer Research James McGill Chair, McGill University. Founder and Former Director of the Goodman Cancer Research Centre. Co-Founder of Mispro Biotech Services. Brian Kennedy, Ph. D. Former Senior Director of Biology and Site Lead for Cardiovascular and Metabolic Diseases at Merck Frosst. Discovered and led the PTP-1B program. Co-Founder of Kaneq Pharma and Kaneq Bioscience.

4

Home

http://www.kanyrpharma.com/home.html

Kanyr, the world’s leading PTP inhibitor company. Capitalize on existing expertise and local resources. Minimal competition in the PTP area. Many PTP targets available and left untapped. Montreal, QC, Canada. Contact: Daniel Bouthillier 514-402-1764. Email us: daniel.bouthillier@kaneq.ca. PTPs have long been thought to be undruggable . Recent successes. Show that this is no longer the case:. PTPβ inhibitor in P1 development for diabetic macular edema. PTP Inhibitor Immunotherapy ImmunyrTM Technology.

UPGRADE TO PREMIUM TO VIEW 0 MORE

TOTAL PAGES IN THIS WEBSITE

4

LINKS TO THIS WEBSITE

aligo.ca

Entreprises dérivées | Aligo

http://www.aligo.ca/realisations/entreprises-derivees

À propos de nous. COMMENT NOUS TRAITONS NOS DOSSIERS. Aligo compte comme entreprises dérivées celles qui répondent aux critères suivants :. Les entreprises doivent avoir été formées soit :. Par une licence d'une technologie provenant d'une université partenaire d'Aligo et valorisée par Aligo ;. Pour financer la recherche dans les universités partenaires d’Aligo afin de développer la technologie pour laquelle la société obtiendra une licence ;. Institution - Partenaire universitaire*. Université du Québec...

UPGRADE TO PREMIUM TO VIEW 1 MORE

TOTAL LINKS TO THIS WEBSITE

2

OTHER SITES

kanyouxi.com

首页_看游戏_新浪游戏_新浪网

爱看不看天高任你飞谕见天空.

kanyouxi.com.cn

首页_看游戏_新浪游戏_新浪网

爱看不看天高任你飞谕见天空.

kanyouxun.com

长沙市芙蓉区电动葫芦升降机_长沙市芙蓉区电动葫芦遥控器_长沙市芙蓉区电动葫芦配件_长沙市芙蓉区电动葫芦电机-长沙市芙蓉区鹏露电动葫芦集团有限公司

kanypuruwa.com

www.kanypuruwa.com

WwwEcuaWeb.NET Domain and Hosting Services USA 1-(786)-264-1426 Ecuador (04)-2136-400. Notice: This domain name expired on 07/03/15 and is pending renewal or deletion. This domain registration expired on 07/03/2015. Do you own this domain? Visit www.EcuaWeb.NET Domain and Hosting Services USA 1-(786)-264-1426 Ecuador (04)-2136-400. Use of this Site is subject to express Terms of Use. By using this Site, you signify that you agree to be bound by these Terms of Use. Which were last revised on.

kanyreview.com

Inquire about this domain.

kanyrpharma.com

Home

Kanyr, the world’s leading PTP inhibitor company. Capitalize on existing expertise and local resources. Minimal competition in the PTP area. Many PTP targets available and left untapped. Montreal, QC, Canada. Contact: Daniel Bouthillier 514-402-1764. Email us: daniel.bouthillier@kaneq.ca. PTPs have long been thought to be undruggable . Recent successes. Show that this is no longer the case:. PTPβ inhibitor in P1 development for diabetic macular edema. PTP Inhibitor Immunotherapy ImmunyrTM Technology.

Website Suspension

Kanysa.com

Website Suspension

Inicio

Todos los Derechos Reservados Diseño De La Rosa Creativo 2014. Se prohíbe la reproducción total o parcial de cualquiera de los contenidos que aquí aparezca, así como su traducción a cualquier idioma. Sin autorización escrita de su titular.

kanysazejam.com

.:: Kanysazejam-" کانی ساز جم" تولیدکننده برتر خاک بنتونیت اکتیو شده اسيدي در ایران ::.

شنبه 11 فروردین 1397. کانی ساز جم" تولیدکننده برتر خاک بنتونیت اکتیو شده اسيدي در ایران. درباره كاني ساز جم. ارتباط با کانی ساز جم. محصولات کانی ساز جم. درباره کانی ساز جم. به کانی ساز جم خوش آمدید. برای اولین بار در ايران. کانی ساز جم" تولیدکننده برتر خاک بنتونیت اکتیو شده اسیدی در ایران. شرکت تولید و فرآوری کانی سازی جم تولیدکننده برتر خاک بنتونیت اکتیو شده اسیدی در ایران برای تصفیه کلیه روغن های نباتی و معدنی در گریدهای مختلف و خاص می باشد . در حال به روز رسانی. درباره كاني ساز جم. درباره کانی ساز جم.